Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

DR REDDYS LABS SA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 35
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 41
  • 0 comments

FDA approve ESMOLOL HYDROCHLORIDE

Comment Full text

HIKMA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 40
  • 0 comments

FDA approve AMIKACIN SULFATE

Comment Full text

SANDOZ

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 28
  • 0 comments

FDA approve GLATIRAMER ACETATE

Comment Full text

ABON PHARMS LLC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 44
  • 0 comments

FDA approve SUCRALFATE

Comment Full text

SUN PHARM

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 35
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

Y-MABS THERAPEUTICS INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 37
  • 0 comments

FDA approve NAXITAMAB-GQGK

Comment Full text

WES PHARMA INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 31
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

BARR

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 44
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE

Comment Full text

GLAND PHARMA LTD

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 44
  • 0 comments

FDA approve GANIRELIX ACETATE

Comment Full text
  • Previous
  • 498
  • 499
  • 500
  • 501
  • 502
  • Next

Search

News categories

  • Technical Exchange News(14694)
  • Event(6229)
  • SEC News(393628)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239516)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin